Effects of dexamethasone on early cognitive decline after cardiac surgery; A randomised controlled trial

European Journal of Anaesthesiology

Volumn 34, Issue 11, 2017, Pages 776-784

  Glumac, Sandro ^a   Kardum, Goran ^b   Sodic, Lidija ^c   Supe Domic, Daniela ^a   Karanovic, Nenad ^a,d  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

^c Clinical Department of Neurology   (Croatia)

^d UNIVERSITY OF SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DEXAMETHASONE; PLACEBO; PROTEIN S100B; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL OUTCOME; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; HEART SURGERY; HUMAN; INFLAMMATION; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGIC DISEASE ASSESSMENT; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGICAL TEST; POSTOPERATIVE COGNITIVE DECLINE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL RISK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL; AGED; INTRAVENOUS DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PSYCHOLOGY; TRENDS;

AGED; ANTI-INFLAMMATORY AGENTS; CARDIAC SURGICAL PROCEDURES; COGNITIVE DYSFUNCTION; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 85030696894     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000647     Document Type: Article

References (35)

1. van Harten AE, Scheeren TW, Absalom AR. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia. Anaesthesia 2012; 67:280-293.
2. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344:395-402.
3. Knipp SC, Matatko N, Wilhelm H, et al. Cognitive outcomes three years after coronary artery bypass surgery: relation to diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2008; 85:872-879.
4. Blumenthal JA, Mahanna EP, Madden DJ, et al. Methodological issues in the assessment of neuropsychologic function after cardiac surgery. Ann Thorac Surg 1995; 59:1345-1350.
5. Patel N, Minhas JS, Chung EM. Risk factors associated with cognitive decline after cardiac surgery: A systematic review. Cardiovasc Psychiatry Neurol 2015; 2015:370612.
6. Polunina AG, Golukhova EZ, Guekht AB, et al. Cognitive dysfunction after on-pump operations: neuropsychological characteristics and optimal core battery of tests. Stroke Res Treat 2014; 2014:302824.
7. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative Ischemia research group and the Ischemia research and education foundation investigators. N Engl J Med 1996; 335:1857-1863.
8. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96:3542-3548.
9. Parolari A, Camera M, Alamanni F, et al. Systemic inflammation after onpump and off-pump coronary bypass surgery: A one-month follow-up. Ann Thorac Surg 2007; 84:823-828.
10. Patel N, Minhas JS, Chung EM. Intraoperative embolization and cognitive decline after cardiac surgery: A systematic review. Semin Cardiothorac Vasc Anesth 2016; 20:225-231.
11. Kozora E, Kongs S, Collins JF, et al. Cognitive outcomes after on-versus off-pump coronary artery bypass surgery. Ann Thorac Surg 2010; 90:1134-1141.
12. Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of off-pump and onpump coronary-artery bypass grafting at 1 year. N Engl J Med 2013; 368:1179-1188.
13. Jansen NJ, van Oeveren W, van Vliet M, et al. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg 1991; 5:211-217.
14. Santonocito C, De Loecker I, Donadello K, et al. C-reactive protein kinetics after major surgery. Anesth Analg 2014; 119:624-629.
15. Marchi N, Rasmussen P, Kapural M, et al. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 2003; 21:109-121.
16. Diegeler A, Hirsch R, Schneider F, et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg 2000; 69:1162-1166.
17. Jö nsson H, Johnsson P, Alling C, et al. S100b after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68:2202-2208.
18. Westaby S, Saatvedt K, White S, et al. Is there a relationship between serum S-100beta protein and neuropsychologic dysfunction after cardiopulmonary bypass J Thorac Cardiovasc Surg 2000; 119: 132-137.
19. Silva FP, Schmidt AP, Valentin LS, et al. S100B protein and neuronspecific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study. Eur J Anaesthesiol 2016; 33:681-689.
20. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607.
21. Murkin JM, Newman SP, Stump DA, et al. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg 1995; 59:1289-1295.
22. Lezak MD. Neuropsychological assessment. New York, USA: Oxford University Press; 1995.
23. Hope AT, Woolman PS, Gray WM, et al. A system for psychomotor evaluation; design, implementation and practice effects in volunteers. Anaesthesia 1998; 53:545-550.
24. Ottens TH, Dieleman JM, Sauer AM, et al. Effects of dexamethasone on cognitive decline after cardiac surgery: A randomized clinical trial. Anesthesiology 2014; 121:492-500.
25. Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59:12-19.
26. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101:1481-1483.
27. Hensel M, Volk T, Dö cke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89:93-104.
28. Abraha HD, Butterworth RJ, Bath PM, et al. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997; 34:366-370.
29. Whitlock RP, Devereaux PJ, Teoh KH, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): A randomised, double-blind, placebo-controlled trial. Lancet 2015; 386:1243-1253.
30. Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: A randomized controlled trial. JAMA 2012; 308:1761-1767.
31. van Dijk D, Moons KG, Nathoe HM, et al. Cognitive outcomes five years after not undergoing coronary artery bypass graft surgery. Ann Thorac Surg 2008; 85:60-64.
32. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57:925-935.
33. Piccoli M, Cerquetani E, Pastena G, et al. 'Lone' increase in C-reactive protein after cardiac surgery: prevalence, clinical characteristics, inhospital course, and prognostic value. Eur J Cardiovasc Prev Rehabil 2008; 15:482-487.
34. Blumenthal JA, Madden DJ, Burker EJ, et al. A preliminary study of the effects of cardiac procedures on cognitive performance. Int J Psychosom 1991; 38:13-16.
35. Landis RC. 20 years on: Is it time to redefine the systemic inflammatory response to cardiothoracic surgery J Extra Corpor Technol 2015; 47:5-9.